A proteoglycan isolated from Ganoderma lucidum attenuates diabetic kidney disease by inhibiting oxidative stress-induced renal fibrosis both in vitro and in vivo DOI

Yanna Pan,

Ying Zhang, Jiaqi Li

et al.

Journal of Ethnopharmacology, Journal Year: 2023, Volume and Issue: 310, P. 116405 - 116405

Published: March 24, 2023

Language: Английский

New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism DOI Open Access
Stéphanie Eid, Kelli M. Sas, Steven F. Abcouwer

et al.

Diabetologia, Journal Year: 2019, Volume and Issue: 62(9), P. 1539 - 1549

Published: July 25, 2019

Language: Английский

Citations

373

‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue DOI Open Access
Laura M. Pérez, Helios Pareja‐Galeano, Fabián Sanchis‐Gomar

et al.

The Journal of Physiology, Journal Year: 2016, Volume and Issue: 594(12), P. 3187 - 3207

Published: March 1, 2016

The increasing ageing of our societies is accompanied by a pandemic obesity and related cardiometabolic disorders. Progressive dysfunction the white adipose tissue increasingly recognized as an important hallmark process, which in turn contributes to metabolic alterations, multi-organ damage systemic pro-inflammatory state ('inflammageing'). On other hand, obesity, paradigm dysfunction, shares numerous biological similarities with normal process such chronic inflammation multi-system alterations. Accordingly, understanding interplay between accelerated critical gain insight into general well pathophysiology conditions. Here we postulate concept 'adipaging' illustrate common links fact that, great extent, obese adults are prematurely aged individuals.

Language: Английский

Citations

185

The diabetogenic action of statins — mechanisms and clinical implications DOI

D. J. Betteridge,

Rafael Carmena

Nature Reviews Endocrinology, Journal Year: 2015, Volume and Issue: 12(2), P. 99 - 110

Published: Dec. 15, 2015

Language: Английский

Citations

162

Oxidative stress in chronic kidney disease DOI Creative Commons
Xiao Chun Ling, Ko‐Lin Kuo

Renal Replacement Therapy, Journal Year: 2018, Volume and Issue: 4(1)

Published: Dec. 1, 2018

For patients with chronic kidney disease (CKD), the leading cause of mortality is cardiovascular disease. One main novel risk factors oxidative stress, which occurs when there overproduction reactive oxygen species (ROS) and/or a reduction in antioxidant defense capacity. Oxidative stress involved progression renal injury, pathogenesis atherosclerosis, and exacerbation burden CKD patients. In addition, uremic- dialysis-associated these further contribute to via proinflammatory state, including exposure dialysate endotoxins or use bioincompatible hemodialysis dialyzer membranes. Consequences include amyloidosis, anemia. Strategies combat therapies such as vitamins C E N-acetylcysteine (NAC). While strategies are promising, few interventional studies have examined their effects until now. light disparate experimental clinical data, large, randomized, long-term required establish efficacy safety

Language: Английский

Citations

138

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy DOI Creative Commons

Mariël F. van Stee,

Albert A. de Graaf,

Albert K. Groen

et al.

Cardiovascular Diabetology, Journal Year: 2018, Volume and Issue: 17(1)

Published: June 30, 2018

Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug metformin a cholesterol-lowering statin. However, both drugs act on glucose lipid metabolism which could lead to adverse effects when used in as compared monotherapy. In this review, proposed molecular mechanisms action statin patients dyslipidemia are critically assessed, hypothesis underlying interactions between these is developed.

Language: Английский

Citations

126

The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study DOI
Angélica Saraí Jiménez‐Osorio, Wylly Ramsés García‐Niño, Susana González-Reyes

et al.

Journal of Renal Nutrition, Journal Year: 2016, Volume and Issue: 26(4), P. 237 - 244

Published: Feb. 22, 2016

Language: Английский

Citations

125

Aloe vera and Streptozotocin-Induced Diabetes Mellitus DOI Open Access
Fatemeh Haghani, Mohammad‐Reza Arabnezhad, Salman Mohammadi

et al.

Revista Brasileira de Farmacognosia, Journal Year: 2022, Volume and Issue: 32(2), P. 174 - 187

Published: March 10, 2022

Language: Английский

Citations

63

Statin initiation and risk of incident kidney disease in patients with diabetes DOI Creative Commons
Shiyu Zhou, Licong Su,

Ruqi Xu

et al.

Canadian Medical Association Journal, Journal Year: 2023, Volume and Issue: 195(21), P. E729 - E738

Published: May 28, 2023

The role of statin therapy in the development kidney disease patients with type 2 diabetes mellitus (DM) remains uncertain. We aimed to determine relationships between initiation and outcomes DM.

Language: Английский

Citations

32

Effects of a Diabetic Microenvironment on Neurodegeneration: Special Focus on Neurological Cells DOI Creative Commons
Vishal Chavda, Dhananjay Yadav, Snehal S. Patel

et al.

Brain Sciences, Journal Year: 2024, Volume and Issue: 14(3), P. 284 - 284

Published: March 15, 2024

Diabetes is a chronic metabolic condition associated with high levels of blood glucose which leads to serious damage the heart, kidney, eyes, and nerves. Elevated brain function cognitive abilities. They also lead various neurological neuropsychiatric disorders, including neurodegeneration decline. High neuronal can cause drastic due neurotoxicity. Astrocytes, type glial cell, play vital role in maintaining through neuron–astrocyte coupling. Hyperglycemia progressive decline networks impairment, contributing dysfunction fostering neurodegenerative environment. In this review, we summarize connections, functions, impairments cells diabetic brain. We effects hyperglycemia on functions

Language: Английский

Citations

9

Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling. DOI

Yaoxia Zhang,

Yuanyuan Qu,

Ruiping Cai

et al.

European Journal of Pharmacology, Journal Year: 2024, Volume and Issue: 976, P. 176699 - 176699

Published: June 1, 2024

Language: Английский

Citations

9